Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer

Systemic inflammation is currently regarded as a hallmark of cancer. This study aimed to accurately clarify the prognostic value of various inflammatory markers in patients with stage IV cancer.